Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patti Stampone

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Australasian Journal of Dermatology|October 13, 2006
Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeksChris Quirk, Kurt Gebauer, Mary Owens, et al.
Chest|December 12, 2002
Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled studyAnjuli Nayak, Robert Lanier, Steven Weinstein, et al.
Journal of the American Academy of Dermatology|April 21, 2004
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studiesJohn Geisse, Ivor Caro, Jane Lindholm, et al.
European Journal of Dermatology : EJD|September 21, 2005
Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in EuropeHarald Gollnick, Carlos Guillén Barona, Ronald G J Frank, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Australasian Journal of Dermatology|October 13, 2006
Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeksChris Quirk, Kurt Gebauer, Mary Owens, et al.
Chest|December 12, 2002
Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled studyAnjuli Nayak, Robert Lanier, Steven Weinstein, et al.
Journal of the American Academy of Dermatology|April 21, 2004
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studiesJohn Geisse, Ivor Caro, Jane Lindholm, et al.
European Journal of Dermatology : EJD|September 21, 2005
Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in EuropeHarald Gollnick, Carlos Guillén Barona, Ronald G J Frank, et al.
Pageof 1